Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial
…, JA Sorensen, J Thomsen, P Grupe… - Annals of surgical …, 2004 - Springer
Background: The aim was to determine the reliability and reproducibility of sentinel node
biopsy (SNB) as a staging tool in head and neck squamous cell carcinoma (HNSCC) for T1/2 …
biopsy (SNB) as a staging tool in head and neck squamous cell carcinoma (HNSCC) for T1/2 …
Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules
…, FN Bennedbæk, SJ Bonnema, P Grupe… - European journal of …, 2007 - academic.oup.com
Objective To compare the efficacy of interstitial laser photocoagulation (ILP) with radioiodine
in hot thyroid nodules. Design Thirty consecutive outpatients with subclinical or mild …
in hot thyroid nodules. Design Thirty consecutive outpatients with subclinical or mild …
Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double …
…, VE Nielsen, H Boel-Jørgensen, P Grupe… - The Journal of …, 2007 - academic.oup.com
Introduction: The effect of 131 I therapy amplification by recombinant human (rh) TSH
prestimulation in very large goiters has not been evaluated in a double-blinded, placebo-controlled …
prestimulation in very large goiters has not been evaluated in a double-blinded, placebo-controlled …
Dual-time-point imaging and delayed-time-point fluorodeoxyglucose-PET/computed tomography imaging in various clinical settings
Fluorodeoxyglucose (FDG)-PET/computed tomography (CT) imaging enables clinicians to
assess cancer biology and perform staging, restaging, and treatment monitoring of cancers. 1 …
assess cancer biology and perform staging, restaging, and treatment monitoring of cancers. 1 …
Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective …
…, H Boel-Jørgensen, P Grupe… - Archives of Internal …, 2006 - jamanetwork.com
Background Use of recombinant human thyrotropin increases the thyroid radioiodine (iodine
131 [ 131 I]) uptake and may have a role in the context of 131 I therapy of benign goiter. …
131 [ 131 I]) uptake and may have a role in the context of 131 I therapy of benign goiter. …
Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter
S Fast, VE Nielsen, P Grupe… - The Journal of …, 2012 - academic.oup.com
Objective: The objective of the study was to evaluate the long-term outcome of recombinant
human TSH (rhTSH)-augmented radioiodine ( 131 I) therapy for benign multinodular …
human TSH (rhTSH)-augmented radioiodine ( 131 I) therapy for benign multinodular …
Modified-Release Recombinant Human TSH (MRrhTSH) Augments the Effect of 131I Therapy in Benign Multinodular Goiter: Results from a Multicenter International …
…, C Marriott, I Rachinsky, P Grupe… - The Journal of …, 2011 - academic.oup.com
Background: Recombinant human TSH (rhTSH) can be used to enhance 131 I therapy for
shrinkage of multinodular goiter (MG). Objective, Design, and Setting: The objective of the …
shrinkage of multinodular goiter (MG). Objective, Design, and Setting: The objective of the …
Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration
…, VE Nielsen, H Boel-Jørgensen, P Grupe… - The Journal of …, 2008 - academic.oup.com
Introduction: The impact on tracheal anatomy and respiratory function of recombinant human
(rh)TSH-stimulated 131 I therapy in patients with goiter is not clarified. Methods: In a double-…
(rh)TSH-stimulated 131 I therapy in patients with goiter is not clarified. Methods: In a double-…
Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy
S Fast, L Hegedus, P Grupe, VE Nielsen… - The Journal of …, 2010 - academic.oup.com
Context and Objective: Stimulation with recombinant human TSH (rhTSH) before radioiodine
( 131 I) therapy augments goiter volume reduction (GVR). Observations indicate that rhTSH …
( 131 I) therapy augments goiter volume reduction (GVR). Observations indicate that rhTSH …
Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study
S Fast, VE Nielsen, P Grupe, SJ Bonnema… - Journal of Nuclear …, 2009 - Soc Nuclear Med
Prestimulation with recombinant human thyroid-stimulating hormone (rhTSH) augments
radioiodine 131 I therapy for benign nontoxic multinodular goiter. The purpose of this study was …
radioiodine 131 I therapy for benign nontoxic multinodular goiter. The purpose of this study was …